KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Clover Health Investments (CLOV) Net Margin (2020 - 2024)

Clover Health Investments' Net Margin history spans 5 years, with the latest figure at 0.17% for Q4 2024.

  • For Q4 2024, Net Margin rose 66.0% year-over-year to 0.17%; the TTM value through Sep 2025 reached 0.03%, down 14.0%, while the annual FY2024 figure was 0.24%, 50.0% up from the prior year.
  • Net Margin reached 0.17% in Q4 2024 per CLOV's latest filing, down from 0.11% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 8.58% in Q2 2020 to a low of 93.12% in Q4 2021.
  • Average Net Margin over 5 years is 16.48%, with a median of 9.19% recorded in 2022.
  • Peak YoY movement for Net Margin: tumbled -5296bps in 2021, then surged 8480bps in 2022.
  • A 5-year view of Net Margin shows it stood at 47.42% in 2020, then tumbled by -96bps to 93.12% in 2021, then soared by 91bps to 8.32% in 2022, then surged by 90bps to 0.83% in 2023, then surged by 79bps to 0.17% in 2024.
  • Per Business Quant, the three most recent readings for CLOV's Net Margin are 0.17% (Q4 2024), 0.11% (Q3 2024), and 0.07% (Q2 2024).